Market Overview

UPDATE: Jefferies Raises Price Target on Salix Pharmaceuticals to $54


According to Jefferies, Salix Pharmaceuticals (NASDAQ: SLXP) price target is raised to $54.

Jefferies said that SLXP posted a big Q4 beat, but this was overshadowed by '12 guidance that was below consensus, as spending needs to escalate. “Our new $54 PT is 20x our 2013E EPS of $2.72, a premium PE we feel is justified given our view that SLXP can grow 20%+ over the next 5-6 years (~1x PEG).”

Salix Pharmaceuticals closed yesterday at $46.14.

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (SLXP)

View Comments and Join the Discussion!

Latest Ratings

POOLStephens & Co.Reiterates196.0
WMCBank of AmericaReiterates10.5
SNBRBank of AmericaMaintains30.0
BYNDExane BNP ParibasInitiates Coverage On
TSGJefferiesInitiates Coverage On18.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPDATE: Jefferies Lowers Price Target on Sina to $99

Notable Put Options Activity in Red Hat